Skip to content

Comparing the effectiveness of Nifedipine and magnesium sulfate in treating preterm labor.

Comparing the effectiveness of Nifedipine and magnesium sulfate in treating preterm labor.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013052113421N1
Enrollment
110
Registered
2015-02-20
Start date
2011-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm labour. Preterm labour without delivery

Interventions

Intervention 1: In Nifedipine group : Patients were treated by 10 mg of nifedipine orally repeated up to 4 dozes per 20/min which was continued by 20mg/4-8hr and then every 12 hours till 48hr or 12hr
Treatment - Drugs
In Nifedipine group : Patients were treated by 10 mg of nifedipine orally repeated up to 4 dozes per 20/min which was continued by 20mg/4-8hr and then every 12 hours till 48hr or 12hr after clinical
In Mg-sulfate group : Patients were treated by 4gr/20min of Mg-Sulfate intravenously which continued by 1g/hr up to 24hr, in case of no contraindications treatment continued till 24hr or for 24hr af

Sponsors

urmia university of medical sciences, deputy of research and technology.
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion: Patients in 27th-36th of Gestation; 4 contractions per 20 min; dilatation of cervices > 1cm; effacement > 85 % ; intact membranes; have gestational age determined by LMP or ultrasonogeraphical study; Not to be included if : any indication for termination of pregnancy; any previous medication as tocolysis ; Placental abruption; infection; contra indictions of ca-blocker usage; primarily, a blood pressure below 90/50; Exclusion : were rupture of membranes; vaginal bleeding; fetal distress; dilatation of cervix >3cm; blood pressure below 90/50 mm Hg.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hampering contractions of labor. Timepoint: 48 hours from beginning of treatments. Method of measurement: observation by gynecologist.

Secondary

MeasureTime frame
Maternal complications : headache, hypotension, dyspnea and tachycardia. Timepoint: 48 hours of medication. Method of measurement: observation and physical examination by gynecologist.;Neonatal outcome : 1st min Apgar score. Timepoint: Just exact after labor. Method of measurement: Physical examination & observation by gynecologist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Fariba nanbakhsh

Urumia University of Medical Science

faribanan@yahoo.com+98 44 3344 5138

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026